4u Created
Image default

Abbott Labs earnings beat by $0.11, revenue topped estimates By Investing.com


© Reuters. Abbott Labs earnings beat by $0.11, revenue topped estimates

Investing.com – Abbott Labs (NYSE: ABT) reported fourth quarter EPS of $1.03, $0.11 better than the analyst estimate of $0.92. Revenue for the quarter came in at $10.1B versus the consensus estimate of $9.62B.


Abbott Labs sees FY 2023 EPS of $4.30-$4.50 versus the analyst consensus of $4.40.

Abbott Labs’s stock price closed at $112.53. It is up 13.11% in the last 3 months and down -6.28% in the last 12 months.

Abbott Labs saw 4 positive EPS revisions and 2 negative EPS revisions in the last 90 days. See Abbott Labs’s stock price’s past reactions to earnings here.

According to InvestingPro, Abbott Labs’s Financial Health score is “great performance“.

Check out Abbott Labs’s , and Abbott Labs’s financials here.

Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com’s earnings calendar


Source link

Related posts

More western tech companies set out Russian exit plans By Reuters

Turkey sets out Russian demands for resumption of Ukraine grain deal By Reuters

Explainer-Will Germany introduce a windfall tax on energy firms? By Reuters